Could a common cholesterol drug help fight ovarian cancer?
Disease control
Completed
This early-phase study tested whether adding simvastatin, a common cholesterol-lowering drug, to standard chemotherapy could slow cancer progression in women with recurrent platinum-sensitive ovarian cancer. 18 participants took simvastatin alongside carboplatin and liposomal dox…
Phase: EARLY_PHASE1 • Sponsor: Marc Goodman • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC